Screening began within three weeks
Our first participant was screened within three weeks of site activation for this Phase 3 ulcerative colitis study, establishing early recruitment momentum.
Phase 3 · Ulcerative colitis
Enrollment goal met early. Every participant completed.
WCR screened its first participant within three weeks of activation, met its enrollment goal well before study enrollment closed, and achieved 100% participant completion with zero screen failures.
Explore the study storyStudy outcome
100%of randomized participants completed the trialWithin 3 weeksactivation to first participant screening
0%screen-failure rate
100%participant completion
Inside the case
Zero screen failures. Enrollment goal met early.
The site recorded a 0% screen-failure rate, with screened participants progressing to randomization. WCR met its enrollment goal well before enrollment closed for the overall study.
Follow-through matched the enrollment result
Every randomized participant completed the trial. Clear expectations before screening, sustained participant relationships, and open communication supported high compliance throughout participation.
The challenge. Our response.
Plan around the procedure burden and visit schedule.
Restrictive eligibility, invasive procedures, and a frequent visit schedule made participant preparation and practical support central to execution.
Restrictive eligibility
The challenge
The study’s eligibility requirements narrowed the pool of candidates who could move forward.
How our team responds
We focus pre-screening on the protocol criteria and discuss the participation commitment early, helping establish both potential eligibility and readiness before screening.
Invasive procedures
The challenge
Required invasive procedures added to the commitment participants needed to consider.
How our team responds
We explain procedure expectations in advance, make time for questions, and discuss visit preparation with participants so they understand the commitment before moving forward.
An intensive visit schedule
The challenge
Frequent visits required participants to make repeated time and travel arrangements.
How our team responds
We discuss availability early, coordinate the visit plan within protocol requirements, and maintain open communication throughout follow-up. Transportation support is available when needed to help address travel barriers.
Study outcome
First screening within three weeks. Goal met early. Zero screen failures. 100% completion.
The participant experience
Keep participants connected beyond the enrollment goal.
Meeting the enrollment goal early was one milestone. Our team paired preparation before screening with participant relationships and open communication throughout follow-up. High compliance accompanied completion by every randomized participant.
Set expectations before screening
We discuss the study commitment early, including what participation will require and whether candidates feel ready to meet those expectations. Pre-screening helps establish a shared understanding before the first screening visit.
Build a working relationship
Participants need a team they can talk to. We build relationships throughout the study and keep communication open so questions and practical concerns can be raised with the site.
Keep the focus on follow-through
Our participant engagement approach continues beyond randomization. We stay connected throughout participation to support retention and compliance with study requirements.
Practical participant support
Help with the journey.
Support through the study.
We provide transportation support when needed to help participants attend study visits. We also discuss scheduling concerns early and maintain open communication throughout participation, helping address the practical barriers that can make follow-through difficult.
The result
First screening within three weeks. Goal met early. Zero screen failures. 100% completion.
Phase 3 · Ulcerative colitis · WCR case study
Your next study
Build your next study
on a stronger start.
Talk with our Miami Lakes and Puerto Rico teams about your protocol, patient population, and the participation demands that matter to your study.